Filters
Catalog peptides
Tumor Antigen Peptide (Customized)

Retatrutide

Name
Retatrutide
Molecular structural formula
CAS Number
2381089-83-2
Formula
C221H342N46O68
MW
4731.33
Sequence Shortening
Y-{Aib}-QGTFTSDYSI-{(α)MeLeu}-LDK-{K(Eicosanedioicacid-γ-Glu-AEEA)}-AQ-{Aib}-AFIEYLLEGGPSSGAPPPS-NH2
Sequence
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{(α)MeLeu}-Leu-Asp-Lys-{Lys(Eicosanedioicacid-γ-Glu-AEEA)}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
InChIKey
MLOLQJNKXBNWFW-SAGGEDDASA-N
DMSO solubility
50 mg/mL
Solubility in water
20 mg/mL
Purity
≥98%
Target
GCGR, GLP Receptor
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Retatrutide is a fatty acid acylated single peptide, a peptide compound with triple agonist activity, also known as a GGG triple agonist. It can act on GLP-1R, GIPR and GCGR simultaneously, combining the glucagon receptor agonism with the GIP and GLP-1 receptor agonism. GLP-1 and GIP, as incretin hormones, can promote insulin secretion, produce satiety, and reduce appetite, while GCG can promote energy consumption and increase lipid metabolism.

pdf
Tirzepatide COA
pdf
Tirzepatide HPLC
pdf
Tirzepatide MS